Gabapentin
Product Images NDC 67296-1709

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67296-1709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This image shows a formula for calculating creatinine clearance (CLCr). The formula uses the patient's age in years, weight in kilograms, and serum creatinine levels in mg/dL, with an adjustment factor of 0.85 for female patients.*

FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

Chemical structure diagram of Gabapentin showing a cyclohexane ring attached to a carbon with amine and carboxyl functional groups.*

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

A line graph depicting mean pain score over an 8-week period with two groups: placebo and Gabapentin 3600 mg/day. The timeline is divided into a 4-week dose titration period followed by a 4-week fixed dose period. Mean pain scores decrease more in the Gabapentin group compared to placebo.*

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

A line graph showing mean pain scores over a 7-week period for Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks with distinct 3-week dose titration and 4-week fixed dose periods, while the y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a decrease in pain scores compared to Placebo over time.*

FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing response rates for two studies. Percentages for placebo (PBO) and gabapentin (GBP) at different dosages (1800, 2400, 3600 mg) are displayed, with GBP groups showing higher percentages of responders compared to placebo.*

FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

A scatter plot showing the percentage difference on the y-axis versus daily doses (mg) on the x-axis for Gabapentin across three studies labeled a, b, and c. Each study data point is represented by different shading: solid black for study a, gray for study b, and white for study c. The plot compares differences at doses around 600, 900, 1200, and 1800 mg daily.*

FDA Label Image

Label (Gabapentin 100 1709)

Label for Gabapentin capsules 100 mg, containing 30 capsules. The product is labeled Rx Only with NDC 67296-1709-3. The label includes storage instructions at controlled room temperature (20-25°C or 68-77°F), lot number 03666AX1, and expiration date 08/20. Manufactured by Strides Shasun Limited, India, and distributed by RedPharm Drug, Inc. in Eden Prairie, MN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.